Haemonetics Corporation · NYSE:HAE
Capital Research Global Investors's stake in Haemonetics Corporation fell to 3.10% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 4, 2025
Capital Research Global Investors's stake in Haemonetics Corporation fell to 3.10%, 1,577,323 shares, as a passive investor on Mar 31, 2025. Filed Apr 4, 2025 (Schedule 13G/A).
- Stake
- 3.10%
- Shares
- 1,577,323
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital Research Global Investors | 3.10% | 1,577,323 |
Source
Related
- Haemonetics Corporation
- Capital Research Global Investors
- Haemonetics Corporation shareholders
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026